You are Here : API facility to boost revenue by 5-10%: Nectar Lifesciences

Friday, 02:29

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the companys revenues by 5-10%.
OCT 18, 2017
03:11 PM

cnbc tv18 shows

All Shows


NSE Closing Bell

NSE Closing Bell kicks off as the market starts to shut shop. AnchorsSenthil Chengalvarayan and Menaka Doshihave it all covered for you - expert closing strategies at the start of the hour, the top 6 stocks in 60 seconds, broader markets decoded on Midcap Minute, update on the derivatives space wi ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Follow us on
Available On